Safe and pain-free vascular access is now the achievable goal for every patient receiving
systemic chemotherapy. The discomfort and anxiety that used to accompany multiple (often …

BACKGROUND Few reports have been made regarding the long term safety of implantable
venous access devices used for the delivery of chemotherapeutic agents. The authors' goals …

Vascular access devices (VADs) are frequently used in patients with cancer. Vascular
access devices can be divided into external catheters and subcutaneous venous access …

As advances in VAD technology continue, the biggest challenge becomes the ability to stay
abreast of all the emerging devices and the evolutions in management and care. Various …

In 149 patients, treated with intermittent continuous infusion of different chemotherapeutic
agents, 169 Port-a-Cath® s® were implanted by qualified surgeons and residents in …

PURPOSE A peripherally implanted central venous access device (PAS Port; Pharmacia
Deltec Inc, St Paul, MN) was evaluated for ease of insertion, functionality, acceptance, and …

Despite the increased availability of vascular access devices, there is limited information
regarding their pattern of use in the clinical setting or the criteria used for their utilization. To …

SAFE, READILY AVAILABLE ANGIOACCESS in the cancer patient is essential for
administration of fluids, chemotherapeutic agents, antibiotics, and a variety of other …

Because of the difficulty in maintaining vascular access in patients receiving aggressive
parenteral chemotherapy, a growing number of patients have had implantation of either …

A variety of devices is now available for venous access in patients requiring long-term
infusions of chemotherapeutic agents, hyperalimentation solutions, blood products or …